Sector: Pharmaceutical PreparationsIndustry: BiotechnologyCountry: USExchange: OTC
DilutionScan read 9 of Evofem Biosciences, Inc.'s SEC filings and found 17 warrant series, 7 convertibles and 1 completed offering on file for EVFM. The latest dilution event on file is an offering on Jul 8, 2026. Analysis updated Nov 1, 2026.
DilutionScan ProEvery instrument in full ยท $59/mo
Covered companies in Biotechnology. All tickers A to Z
LNAILunai Bioworks Inc.
JAGXJaguar Health, Inc.
MTNBMatinas BioPharma Holdings, Inc.
VBIOValion Bio, Inc.
ARTLArtelo Biosciences, Inc.
CDTCDT Equity Inc.
SCNIScinai Immunotherapeutics Ltd. American Depositary Shares
BBLGBone Biologics Corporation
SPRCSciSparc Ltd. Ordinary Shares
VRAXVirax Biolabs Group Limited Ordinary Shares
LABTLakewood-Amedex Biotherapeutics, Inc.
KAPAKairos Pharma, Ltd.
OGENOragenics, Inc.
ELABPMGC Holdings Inc.
PPCBPropanc Biopharma, Inc. Common Stock